Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 4/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | PPARG | P37231 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL521857 | 1.00 | TSHR (0.62) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL996713 | 1.00 | TSHR (0.62) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL13174932 | 1.00 | TSHR (0.62) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL3095945 | 1.00 | TSHR (0.62) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL16004821 | 1.00 | TSHR (0.62) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL8198628 | 1.00 | TSHR (0.62) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL16004847 | 1.00 | TSHR (0.62) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL8191933 | 1.00 | TSHR (0.62) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL23539641 | 0.98 | — | — | |
| SCHEMBL409592 | 0.98 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170319696-A1 | Derivatized Hyperbranched Polyglycerols | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2017-11-09 | — | — | US | disclosed |
| US-9561278-B2 | Derivatized hyperbranched polyglycerols | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2017-02-07 | — | — | US | disclosed |
| US-20160114040-A1 | Derivatized Hyperbranched Polyglycerols | CENTRE FOR DRUG RESEARCH AND DEVELOPMENT (CA) | 2016-04-28 | — | — | US | disclosed |
| US-9186410-B2 | Derivatized hyperbranched polyglycerols | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2015-11-17 | — | — | US | disclosed |
| EP-2774941-A1 | Branched polycarboxylate ethers | Construction Research & Technology GmbH (DE) | 2014-09-10 | — | — | EP | disclosed |
| US-20130122112-A1 | Derivatized Hyperbranched Polyglycerols | CENTRE FOR DRUG RESEARCH AND DEVELOPMENT (CA) | 2013-05-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160114040-A1 | Derivatized Hyperbranched Polyglycerols | DDOST, UGCG, DAD1 | TSHR 4684/4885SMN1; SMN2 3829/4885ALDH1A1 348/4885 |
| US-20130122112-A1 | Derivatized Hyperbranched Polyglycerols | DDOST, UGCG, DAD1 | TSHR 4684/4885SMN1; SMN2 3829/4885ALDH1A1 348/4885 |
| US-20170319696-A1 | Derivatized Hyperbranched Polyglycerols | DDOST, UGCG, DAD1 | TSHR 4684/4885SMN1; SMN2 3829/4885ALDH1A1 348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.